Register here to attend:
Register Here For
Join us for an informative webinar catered to meet the needs of those seeking a comprehensive guide into the most awaited Italian Sunshine Act. You will get the opportunity to deep dive into the intricacies of the Act to enable you to be well prepared for the storm.
This webinar welcomes participants to listen to a discussion by industry leaders, including: leading Life Sciences global attorneys and Chief Compliance Officers, as well as industry insiders who will provide invaluable insights and expert perspectives.
Sylvia Asghar Attorney (UK) Vector Health, Dr. Klaus Geldsetzer Ph.D. Pharmacology Former CCO at Santen, Ned Mumtaz Former Director, Pfizer, Edoardo Lazzarini Ethics & Compliance Officer Southern Europe (Italy, Spain and Portugal) – (formerly GSK CH) Haleon.
Discover the dos and don’ts of the Italian Sunshine Act and gain insights into how the upcoming changes will impact the pharmaceutical and medical device industry. Don’t miss out on our enlightening webinar where our experts will provide valuable guidance for navigating the complexities of the Italian Sunshine Act and its implications for global transparency reporting.
Interact with our expert panel to stay up-to-date on critical updates and recommended best practices. During this webinar, you’ll uncover vital information, including:
Recent changes in the Italian transparency regulation
How to stay compliant with the Italian Sunshine Act
Strategies to ensure accurate and timely reporting
Suggested best practice
Q&A session with industry specialists
Don’t miss this opportunity to enhance your understanding of the Italian Sunshine Act. Register now to interact with our speakers and stay compliant with Italian transparency reporting laws.
Get In Touch
We’d love to hear from you
237 Kearny Street, Suite 294, San Francisco, CA 94108